Genomics

Dataset Information

0

Pro-immunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy [B16-OVA treated with MEKi, CD40, in vivo]


ABSTRACT: Pro-immunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy [B16-OVA treated with MEKi, CD40, in vivo]

PROVIDER: PRJNA604032 | ENA |

REPOSITORIES: ENA

Similar Datasets

2020-02-05 | GSE144570 | GEO
2020-01-24 | GSE144146 | GEO
2020-01-24 | GSE144139 | GEO
2020-01-24 | GSE144145 | GEO
2020-01-24 | GSE144161 | GEO
2020-01-24 | GSE144166 | GEO
2020-01-27 | GSE144128 | GEO
| PRJNA602904 | ENA
| PRJNA602881 | ENA
| PRJNA602874 | ENA